Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

New multiple sclerosis clinical trial

The Montreal Neurological Institute is spearheading a new MS study to find a treatment that does not increase a patients’ vulnerability to COVID-19. Study lead, Dr. Alex Saveriano joins Global’s Laura Casella to talk about the open call for participants to enlist in the clinical trial.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article